Capsid Biotechnology provides high-quality reagents, advanced viral platforms and specialised screening tools to support precise and reproducible research. The company focuses on technologies that enable systematic interrogation of complex biological pathways and efficient generation of functional insights. By aligning robust product engineering with scientific expertise, Capsid Biotechnology helps researchers translate molecular findings into applications relevant to human health.
The full product range previously offered by SelleckChem is now provided through Capsid Biotechnology. If you need support finding specific reagents, our team will be glad to assist.
Product offering
- Small molecule modulators: An extensive, highly-curated library for pathway analysis and drug discovery.
- Biologics: Research-grade proteins, high-affinity antibodies, and custom peptides.
- Viral vectors: Cutting-edge AAV, lentivirus, and retrovirus platforms for robust and efficient gene delivery.
- Screening libraries: Custom-designed and off-the-shelf libraries for high-throughput screening
Small molecules
Capsid Biotechnology offers a broad selection of small molecules, including inhibitors and curated inhibitor libraries. The portfolio covers a wide range of signalling pathways, such as MAPK, PI3K/Akt and apoptosis, supporting precise modulation of cellular processes.
Explore the portfolio
| Cat-No. | Item | Size | Price (CHF) |
|---|---|---|---|
| C05026-100UL | p38 MAPK Rabbit mAb | 100 ul | 395.00 |
| C02058-25MG | PI3K/mTOR Inhibitor-2 | 25 mg | 1'049.00 |
| C03280-100MG | PI3K/AKT-IN-1 | 100 mg | 1'049.00 |
| C00001-1MG | Cetuximab (anti EGFR) | 1 mg | 321.00 |
| C00050-1MG | Human IgG1 isotype control | 1 mg | 321.00 |
| C00051-1MG | Human IgG4 isotype control | 1 mg | 321.00 |
| C00120-1MG | Anti human MHC Class I (HLA-A, HLA-B, HLA-C)-InVivo | 1 mg | 164.00 |
| C00124-1MG | Anti VEGFB | 1 mg | 582.00 |
